-
1
-
-
0034707105
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
-
Bombardier C., Laine L., Reicin A.et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 343:2000;1520-1528.
-
(2000)
N Engl J Med
, vol.343
, pp. 1520-1528
-
-
Bombardier, C.1
Laine, L.2
Reicin, A.3
-
2
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: A randomized, controlled trial
-
Silverstein F.E., Faich G., Goldstein J.L.et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study. a randomized, controlled trial JAMA. 284:2000;1247-1255.
-
(2000)
JAMA
, vol.284
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
-
3
-
-
0032851480
-
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
-
Laine L., Harper S., Simon T.et al. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology. 117:1999;776-783.
-
(1999)
Gastroenterology
, vol.117
, pp. 776-783
-
-
Laine, L.1
Harper, S.2
Simon, T.3
-
4
-
-
0033601079
-
Adverse upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
-
Langman M.J., Jensen D.M., Watson D.J.et al. Adverse upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. JAMA. 282:1999;1929-1933.
-
(1999)
JAMA
, vol.282
, pp. 1929-1933
-
-
Langman, M.J.1
Jensen, D.M.2
Watson, D.J.3
-
5
-
-
0035934070
-
Risk of cardiovascular events associated with selective COX-2 inhibitors
-
Mukherjee D., Nissen S.E., Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 286:2001;954-959.
-
(2001)
JAMA
, vol.286
, pp. 954-959
-
-
Mukherjee, D.1
Nissen, S.E.2
Topol, E.J.3
-
6
-
-
0021801297
-
Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
-
Carmichael J., Shankel S.W. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med. 78:1985;992-1000.
-
(1985)
Am J Med
, vol.78
, pp. 992-1000
-
-
Carmichael, J.1
Shankel, S.W.2
-
7
-
-
0025844875
-
The role of prostaglandins in NSAID-induced renal dysfunction
-
Toto R.D. The role of prostaglandins in NSAID-induced renal dysfunction. J Rheumatol. 28:1991;22-25.
-
(1991)
J Rheumatol
, vol.28
, pp. 22-25
-
-
Toto, R.D.1
-
8
-
-
0034702914
-
Cyclooxygenase-1 and -2 -dependent prostacyclin formation in patients with atherosclerosis
-
Belton O., Byrne D., Kearney D., Leahy A., Fitzgerald D.J. Cyclooxygenase-1 and -2 -dependent prostacyclin formation in patients with atherosclerosis. Circulation. 102:2000;840-845.
-
(2000)
Circulation
, vol.102
, pp. 840-845
-
-
Belton, O.1
Byrne, D.2
Kearney, D.3
Leahy, A.4
Fitzgerald, D.J.5
-
9
-
-
0032867546
-
Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly
-
Nantel F., Meadows E., Denis D.et al. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett. 457:1999;475-477.
-
(1999)
FEBS Lett
, vol.457
, pp. 475-477
-
-
Nantel, F.1
Meadows, E.2
Denis, D.3
-
10
-
-
0032718593
-
The macula densa is worth its salt
-
Schnermann J., Briggs J.P. The macula densa is worth its salt. J Clin Invest. 104:1999;1007-1009.
-
(1999)
J Clin Invest
, vol.104
, pp. 1007-1009
-
-
Schnermann, J.1
Briggs, J.P.2
-
11
-
-
0013271607
-
Weighing the renal effects of NSAIDs and COX-2 inhibitors
-
Weir M.R., Froch L. Weighing the renal effects of NSAIDs and COX-2 inhibitors. Clinical Dilemmas. 1:2000;3-12.
-
(2000)
Clinical Dilemmas
, vol.1
, pp. 3-12
-
-
Weir, M.R.1
Froch, L.2
-
12
-
-
0033428385
-
Effects of nonsteroidal anti-inflammatory drugs on renal function: Focus on cyclooxygenase-2-selective inhibition
-
Brater D.C. Effects of nonsteroidal anti-inflammatory drugs on renal function. focus on cyclooxygenase-2-selective inhibition Am J Med. 107(Suppl. 6A):1999;65S-71S.
-
(1999)
Am J Med
, vol.107
, Issue.SUPPL. 6A
-
-
Brater, D.C.1
-
13
-
-
0025934766
-
Nonsteroidal anti-inflammatory drugs: Effects on kidney function
-
Whelton A., Hamilton C.W. Nonsteroidal anti-inflammatory drugs. effects on kidney function J Clin Pharmacol. 31:1991;588-598.
-
(1991)
J Clin Pharmacol
, vol.31
, pp. 588-598
-
-
Whelton, A.1
Hamilton, C.W.2
-
14
-
-
0032777567
-
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
-
Rossat J., Maillard M., Nussberger J., Brunner H.R., Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther. 66:1999;76-84.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 76-84
-
-
Rossat, J.1
Maillard, M.2
Nussberger, J.3
Brunner, H.R.4
Burnier, M.5
-
15
-
-
0034701938
-
Effects of celecoxib and naproxen on renal function in the elderly
-
Whelton A., Schulman G., Wallemark C.et al. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med. 160:2000;1465-1470.
-
(2000)
Arch Intern Med
, vol.160
, pp. 1465-1470
-
-
Whelton, A.1
Schulman, G.2
Wallemark, C.3
-
16
-
-
0032948948
-
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
-
Catella-Lawson F., McAdam B., Morrison B.W.et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 289:1999;735-741.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 735-741
-
-
Catella-Lawson, F.1
McAdam, B.2
Morrison, B.W.3
-
17
-
-
0034604272
-
Effects of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial
-
Swan S.K., Rudy D.W., Lasseter K.C.et al. Effects of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med. 133:2000;1-9.
-
(2000)
Ann Intern Med
, vol.133
, pp. 1-9
-
-
Swan, S.K.1
Rudy, D.W.2
Lasseter, K.C.3
-
18
-
-
0027472279
-
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure
-
Pope J.E., Anderson J.J., Felson D.T. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 153:1993;477-484.
-
(1993)
Arch Intern Med
, vol.153
, pp. 477-484
-
-
Pope, J.E.1
Anderson, J.J.2
Felson, D.T.3
-
19
-
-
0028580588
-
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
-
Johnson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 121:1994;289-300.
-
(1994)
Ann Intern Med
, vol.121
, pp. 289-300
-
-
Johnson, A.G.1
Nguyen, T.V.2
Day, R.O.3
-
20
-
-
0027936602
-
Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
-
Gurwitz J.H., Avorn J., Bohn R.L.et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 272:1994;781-786.
-
(1994)
JAMA
, vol.272
, pp. 781-786
-
-
Gurwitz, J.H.1
Avorn, J.2
Bohn, R.L.3
-
21
-
-
0027251342
-
Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population
-
Chrischilles E.A., Wallace R.B. Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population. J Gerontol. 48:1993;91-96.
-
(1993)
J Gerontol
, vol.48
, pp. 91-96
-
-
Chrischilles, E.A.1
Wallace, R.B.2
-
22
-
-
0024255773
-
Propranolol increases prostacyclin synthesis in patients with essential hypertension
-
Beckmann M.L., Gerber J.G., Byyny R.L., Lo-Verde M., Nies A.S. Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension. 12:1988;582-588.
-
(1988)
Hypertension
, vol.12
, pp. 582-588
-
-
Beckmann, M.L.1
Gerber, J.G.2
Byyny, R.L.3
Lo-Verde, M.4
Nies, A.S.5
-
23
-
-
1842369627
-
Interaction of antihypertensive drugs with anti-inflammatory drugs
-
Polónia J. Interaction of antihypertensive drugs with anti-inflammatory drugs. Cardiology. 88(Suppl. 3):1997;47-51.
-
(1997)
Cardiology
, vol.88
, Issue.SUPPL. 3
, pp. 47-51
-
-
Polónia, J.1
-
24
-
-
0029022404
-
The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil
-
Houston M.C., Weir M., Gray J.et al. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 155:1995;1049-1054.
-
(1995)
Arch Intern Med
, vol.155
, pp. 1049-1054
-
-
Houston, M.C.1
Weir, M.2
Gray, J.3
-
25
-
-
0029112265
-
Influence of nonsteroidal anti-inflammatory drugs on renal function and 24-hour ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients
-
Polónia J., Bonaventura I., Gama G.et al. Influence of nonsteroidal anti-inflammatory drugs on renal function and 24-hour ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens. 13:1995;925-931.
-
(1995)
J Hypertens
, vol.13
, pp. 925-931
-
-
Polónia, J.1
Bonaventura, I.2
Gama, G.3
-
26
-
-
0033763236
-
Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril
-
Morgan T.O., Anderson A., Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 13:2000;1161-1167.
-
(2000)
Am J Hypertens
, vol.13
, pp. 1161-1167
-
-
Morgan, T.O.1
Anderson, A.2
Bertram, D.3
-
27
-
-
0033817582
-
Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients
-
Conlin P.R., Moore T.J., Swartz S.L.et al. Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension. 36:2000;461-465.
-
(2000)
Hypertension
, vol.36
, pp. 461-465
-
-
Conlin, P.R.1
Moore, T.J.2
Swartz, S.L.3
-
28
-
-
0000108965
-
Celecoxib does not increease the risk of cardiac failure, edema, or hypertension compared to NSAIDs: Results from SUCCESS-1, a double blind, randomized trial in 13,274 OA patients
-
(abstract)
-
Whelton A., Singh G., White W.et al. Celecoxib does not increease the risk of cardiac failure, edema, or hypertension compared to NSAIDs. Results from SUCCESS-1, a double blind, randomized trial in 13,274 OA patients Ann Rheumat Dis. 60(Suppl. 1):2001;237. (abstract).
-
(2001)
Ann Rheumat Dis
, vol.60
, Issue.SUPPL. 1
, pp. 237
-
-
Whelton, A.1
Singh, G.2
White, W.3
-
29
-
-
0034041594
-
Rofecoxib, a specific inhibitor of cyclooxygenase-2, with clinical efficacy comparable with that of diclofenac sodium
-
Cannon G.W., Caldwell J.R., Holt P.et al. Rofecoxib, a specific inhibitor of cyclooxygenase-2, with clinical efficacy comparable with that of diclofenac sodium. Arthritis Rheum. 43:2000;978-987.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 978-987
-
-
Cannon, G.W.1
Caldwell, J.R.2
Holt, P.3
-
30
-
-
0002167244
-
Comparative blood pressure effects of rofecoxib, celecoxib and placebo in patients with osteoarthritis (OA): A randomized controlled trial
-
Geba G.P., Polis A.B., Dixon M.E.et al. Comparative blood pressure effects of rofecoxib, celecoxib and placebo in patients with osteoarthritis (OA). a randomized controlled trial Ann Rheum Dis. 60(Suppl. 1):2001;238.
-
(2001)
Ann Rheum Dis
, vol.60
, Issue.SUPPL. 1
, pp. 238
-
-
Geba, G.P.1
Polis, A.B.2
Dixon, M.E.3
-
31
-
-
0035286901
-
Cyclooxygenase-2-specific inhibitors and cardiorenal function: A randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients
-
Whelton A., Fort J.G., Puma J.A.et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function. a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients Am J Ther. 8:2001;85-95.
-
(2001)
Am J Ther
, vol.8
, pp. 85-95
-
-
Whelton, A.1
Fort, J.G.2
Puma, J.A.3
-
32
-
-
0345072560
-
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset
-
Wallberg-Jonsson S., Johansson H., Ohman M.L., Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. a retrospective cohort study from disease onset J Rheumatol. 26:1999;2562-2571.
-
(1999)
J Rheumatol
, vol.26
, pp. 2562-2571
-
-
Wallberg-Jonsson, S.1
Johansson, H.2
Ohman, M.L.3
Rantapaa-Dahlqvist, S.4
-
34
-
-
0034984730
-
C-reactive protein
-
Rosalki S.B. C-reactive protein. Int J Clin Pract. 55(4):2001;269-270.
-
(2001)
Int J Clin Pract
, vol.55
, Issue.4
, pp. 269-270
-
-
Rosalki, S.B.1
-
35
-
-
0035187721
-
Inflammation and coronary heart disease: An overview
-
Koenig W. Inflammation and coronary heart disease. an overview Cardiol Rev. 9:2001;31-35.
-
(2001)
Cardiol Rev
, vol.9
, pp. 31-35
-
-
Koenig, W.1
-
36
-
-
0035799341
-
Inflammation and thrombosis: The clot thickens
-
Libby P., Simon D.I. Inflammation and thrombosis. the clot thickens Circulation. 103:2001;1718-1720.
-
(2001)
Circulation
, vol.103
, pp. 1718-1720
-
-
Libby, P.1
Simon, D.I.2
-
37
-
-
0033673612
-
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen and naproxen on COX-2 versus COX-1 in healthy volunteers
-
Van Hecken A., Schwartz J.I., Depré M.et al. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen and naproxen on COX-2 versus COX-1 in healthy volunteers. J Clin Pharmacol. 40:2000;1109-1120.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 1109-1120
-
-
Van Hecken, A.1
Schwartz, J.I.2
Depré, M.3
-
38
-
-
0037182013
-
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction
-
Solomon DH, Glynn RJ, Levin R, et al. Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med 162:1099-1105.
-
Arch Intern Med
, vol.162
, pp. 1099-1105
-
-
Solomon, D.H.1
Glynn, R.J.2
Levin, R.3
-
39
-
-
0037182008
-
Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis
-
Watson DJ, Rhodes T, Cai B, et al. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 162:1105-1110.
-
Arch Intern Med
, vol.162
, pp. 1105-1110
-
-
Watson, D.J.1
Rhodes, T.2
Cai, B.3
-
40
-
-
0037182023
-
Association between naproxen use and protection against acute myocardial infarction
-
Rahme E, Pilote L, LeLorier J. Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med 162:1111-1116.
-
Arch Intern Med
, vol.162
, pp. 1111-1116
-
-
Rahme, E.1
Pilote, L.2
LeLorier, J.3
-
41
-
-
0037182025
-
Selective COX-2 inhibitors, NSAIDs, aspirin and myocardial infarction
-
Dalen JE. Selective COX-2 inhibitors, NSAIDs, aspirin and myocardial infarction. Arch Intern Med 162:1091-1092.
-
Arch Intern Med
, vol.162
, pp. 1091-1092
-
-
Dalen, J.E.1
-
42
-
-
0023805341
-
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
-
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;8607:349-360.
-
(1988)
Lancet
, vol.8607
, pp. 349-360
-
-
-
43
-
-
0028120906
-
I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
-
I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ. 308:1994;81-106.
-
(1994)
BMJ
, vol.308
, pp. 81-106
-
-
-
44
-
-
0035818601
-
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
-
Konstam M.A., Weir M.R., Reicin A.et al. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation. 104:2001;15-23.
-
(2001)
Circulation
, vol.104
, pp. 15-23
-
-
Konstam, M.A.1
Weir, M.R.2
Reicin, A.3
-
45
-
-
0033524421
-
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
-
McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA. 96:272-277.
-
Proc Natl Acad Sci USA
, vol.96
, pp. 272-277
-
-
McAdam, B.F.1
Catella-Lawson, F.2
Mardini, I.A.3
-
46
-
-
0030816051
-
Altered pain perception and inflammatory responses in mice lacking prostacyclin receptor
-
Murata T., Ushikubi F., Matsuoka T.et al. Altered pain perception and inflammatory responses in mice lacking prostacyclin receptor. Nature. 388(6643):1997;678-682.
-
(1997)
Nature
, vol.388
, Issue.6643
, pp. 678-682
-
-
Murata, T.1
Ushikubi, F.2
Matsuoka, T.3
-
47
-
-
0023137593
-
Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs
-
Reilly I.A., FitzGerald G.A. Inhibition of thromboxane formation in vivo and ex vivo. implications for therapy with platelet inhibitory drugs Blood. 69:1987;180-186.
-
(1987)
Blood
, vol.69
, pp. 180-186
-
-
Reilly, I.A.1
FitzGerald, G.A.2
-
48
-
-
0032931328
-
Epidemiology of NSAID-induced gastrointestinal complications
-
Singh G., Triadafilopoulos G. Epidemiology of NSAID-induced gastrointestinal complications. J Rheumatol. 26(Suppl 56):1999;18-24.
-
(1999)
J Rheumatol
, vol.26
, Issue.SUPPL. 56
, pp. 18-24
-
-
Singh, G.1
Triadafilopoulos, G.2
-
49
-
-
0034638656
-
Risk of gastrointestinal hemorrhage with long-term use of aspirin: Meta-analysis
-
Derry S., Loke Y.K. Risk of gastrointestinal hemorrhage with long-term use of aspirin. meta-analysis BMJ. 321:2000;1183-1187.
-
(2000)
BMJ
, vol.321
, pp. 1183-1187
-
-
Derry, S.1
Loke, Y.K.2
-
50
-
-
0000039129
-
COX-2 specific inhibitors - Is there any benefit of using these agents in patients on low dose aspirin (ASA)?
-
Singh G., Goldstein J., Agrawal N.et al. COX-2 specific inhibitors - is there any benefit of using these agents in patients on low dose aspirin (ASA)? Ann Rheum Dis. 60(Suppl. 1):2001;239.
-
(2001)
Ann Rheum Dis
, vol.60
, Issue.SUPPL. 1
, pp. 239
-
-
Singh, G.1
Goldstein, J.2
Agrawal, N.3
|